Clinical Trial Update: Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluated a four-drug combination of temozolomide, vincristine (Oncovin), irinotecan (Camptosar), and an oral antibiotic in children and a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Neoplasms

Drugs mentioned

• Camptosar (irinotecan)
• Oncovin (vincristine)
• Oral antibiotic (unspecified)
• Temodar (Temozolomide)

Snippet

Sponsor: University of Oklahoma | Conditions: Lymphomas, Tumors | Phase 1 | Status: COMPLETED